About
Lily Hechtman is a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and a Professor in the Department of Psychiatry at the Faculty of Medicine and Health Sciences, McGill University. Her work is aligned with the Child Health and Human Development Program, focusing on translational research in attention-deficit/hyperactivity disorder (ADHD).
Research Focus: Dr. Hechtman’s research addresses the social, academic, and emotional challenges faced by individuals with ADHD across the lifespan. She investigates the combination of medication and psychosocial treatments, particularly in maintaining long-term benefits for children, adolescents, and adults with ADHD. Her studies include:
- Developing interventions for children transitioning from elementary to high school
- Parental training and organizational skills programs
- Cognitive-behavioral therapy models
- Long-term outcomes of stimulant medication
- ADHD and risk of substance use
- Driving safety risks in persistent ADHD
Publications: Her recent work contributes to understanding ADHD etiology, treatment efficacy, and functional outcomes through large-scale studies like the Multimodal Treatment Study (MTA) and collaborations with the Université de Montréal.
Advising & Grants: While specific advisees and grants aren’t listed, her research emphasizes longitudinal follow-up strategies and psychosocial interventions. She actively collaborates on cross-institutional projects.
Labs & Teams: Dr. Hechtman is affiliated with the Child Health and Human Development Program at RI-MUHC, which focuses on developmental disorders and translational research.
